OBJECTIVE: Three independent studies have shown that variation in the fat mass and obesity-associated (FTO) gene associates with BMI and obesity. In the present study, the effect of FTO variation on metabolic traits including obesity, type 2 diabetes, and related quantitative phenotypes was examined. RESEARCH DESIGN AND METHODS: The FTO rs9939609 polymorphism was genotyped in a total of 17,508 Danes from five different study groups. RESULTS: In studies of 3,856 type 2 diabetic case subjects and 4,861 normal glucose-tolerant control subjects, the minor A-allele of rs9939609 associated with type 2 diabetes (odds ratio 1.13 [95% CI 1.06-1.20], P = 9 x 10(-5)). This association was abolished when adjusting for BMI (1.06 [0.97-1.16], P = 0.2). Among 17,162 middle-aged Danes, the A-allele associated with overweight (1.19 [1.13-1.24], P = 1 x 10(-12)) and obesity (1.27 [1.20-1.34], P = 2 x 10(-16)). Furthermore, obesity-related quantitative traits such as body weight, waist circumference, fat mass, and fasting serum leptin levels were significantly elevated in A-allele carriers. An interaction between the FTO rs9939609 genotype and physical activity (P = 0.007) was found, where physically inactive homozygous risk A-allele carriers had a 1.95 +/- 0.3 kg/m(2) increase in BMI compared with homozygous T-allele carriers. CONCLUSIONS: We validate that variation in FTO is associated with type 2 diabetes when not adjusted for BMI and with an overall increase in body fat mass. Furthermore, low physical activity seems to accentuate the effect of FTO rs9939609 on body fat accumulation.
OBJECTIVE: Three independent studies have shown that variation in the fat mass and obesity-associated (FTO) gene associates with BMI and obesity. In the present study, the effect of FTO variation on metabolic traits including obesity, type 2 diabetes, and related quantitative phenotypes was examined. RESEARCH DESIGN AND METHODS: The FTOrs9939609 polymorphism was genotyped in a total of 17,508 Danes from five different study groups. RESULTS: In studies of 3,856 type 2 diabetic case subjects and 4,861 normal glucose-tolerant control subjects, the minor A-allele of rs9939609 associated with type 2 diabetes (odds ratio 1.13 [95% CI 1.06-1.20], P = 9 x 10(-5)). This association was abolished when adjusting for BMI (1.06 [0.97-1.16], P = 0.2). Among 17,162 middle-aged Danes, the A-allele associated with overweight (1.19 [1.13-1.24], P = 1 x 10(-12)) and obesity (1.27 [1.20-1.34], P = 2 x 10(-16)). Furthermore, obesity-related quantitative traits such as body weight, waist circumference, fat mass, and fasting serum leptin levels were significantly elevated in A-allele carriers. An interaction between the FTOrs9939609 genotype and physical activity (P = 0.007) was found, where physically inactive homozygous risk A-allele carriers had a 1.95 +/- 0.3 kg/m(2) increase in BMI compared with homozygous T-allele carriers. CONCLUSIONS: We validate that variation in FTO is associated with type 2 diabetes when not adjusted for BMI and with an overall increase in body fat mass. Furthermore, low physical activity seems to accentuate the effect of FTOrs9939609 on body fat accumulation.
Authors: Robert A Scott; Mark E S Bailey; Colin N Moran; Richard H Wilson; Noriyuki Fuku; Masashi Tanaka; Athanasios Tsiokanos; Athanasios Z Jamurtas; Evangelia Grammatikaki; George Moschonis; Yannis Manios; Yannis P Pitsiladis Journal: Eur J Hum Genet Date: 2010-08-18 Impact factor: 4.246
Authors: Mohamed T Hassanein; Helen N Lyon; Thutrang T Nguyen; Ermeg L Akylbekova; Kevin Waters; Guillaume Lettre; Bamidele Tayo; Terrence Forrester; Daniel F Sarpong; Dan O Stram; Johannah L Butler; Rainford Wilks; Jiankang Liu; Loic Le Marchand; Laurence N Kolonel; Xiaofeng Zhu; Brian Henderson; Richard Cooper; Colin McKenzie; Herman A Taylor; Christopher A Haiman; Joel N Hirschhorn Journal: Hum Mol Genet Date: 2010-04-29 Impact factor: 6.150
Authors: Jeanne M McCaffery; George D Papandonatos; Dale S Bond; Michael J Lyons; Rena R Wing Journal: Am J Clin Nutr Date: 2009-02-18 Impact factor: 7.045
Authors: Catharine Wang; Erynn S Gordon; Catharine B Stack; Ching-Ti Liu; Tricia Norkunas; Lisa Wawak; Michael F Christman; Robert C Green; Deborah J Bowen Journal: Clin Trials Date: 2013-11-11 Impact factor: 2.486
Authors: Carina Zabena; José L González-Sánchez; María T Martínez-Larrad; Antonio Torres-García; Jesús Alvarez-Fernández-Represa; Arturo Corbatón-Anchuelo; Milagros Pérez-Barba; Manuel Serrano-Ríos Journal: Obes Surg Date: 2008-10-15 Impact factor: 4.129